Exploration of Targeted Anti-tumor Therapy

Table 1

Patients’ clinical characteristics

Clinical characteristics		Patients n	%
Sex	Male	48	73.8
Sex	Female	17	26.2
Histology	Squamous	28	43.1
Histology	Non-squamous	37	56.9
Age at diagnosis	< 70 years	35	53.8
Age at diagnosis	≥ 70 years	30	46.2
Smoking	Smokers	16	24.6
	Non-smokers	4	6.2
	Former smokers	45	69.2
PS-ECOG (at start of immunotherapy)	≥ 2	9	13.8
PS-ECOG (at start of immunotherapy)	< 2	56	86.2
Metastases sites	Bone	28	43.1
	Pulmonary	47	72.3
	Adrenal	15	23.1
	Lymph nodes	51	78.5
	Pleural	22	33.8
	Cerebral	8	12.3
	Liver	9	13.8
Disease characteristics	Measurable	21	32.3
	Not measurable	44	67.7
	Extra-thoracic localization of disease	33	50.8
	Thoracic localization of disease	32	49.2
Number of sites of metastases	< 4	48	73.8
Number of sites of metastases	≥ 4	17	26.2
Immunotherapy	First line	10	15.4
Immunotherapy	Second line	55	84.6
mOS		23.3 months
mPFS2		5.3 months